Literature DB >> 9036981

Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes.

R N Johnatty1, D D Taub, S P Reeder, S M Turcovski-Corrales, D W Cottam, T J Stephenson, R C Rees.   

Abstract

The production and activation of matrix-degrading proteinases such as the matrix metalloproteinases (MMP) by lymphocytes is likely to be an important factor in facilitating lymphocyte trafficking through the endothelial barrier and the extracellular matrix. Leukocyte infiltration into inflammatory sites occurs as a response to members of the chemokine superfamily and other inflammatory mediators. In the present study, highly purified leukocyte subpopulations were cultured with or without chemokines or cytokines, and their ability to express gelatinolytic MMPs and their inhibitors, the tissue inhibitors of metalloproteinase (TIMPs), was analyzed. In the absence of exogenous stimuli, purified CD4+ T lymphocytes produced similar quantities of proMMP-9 and elevated levels of TIMP-1 compared with PBMC, while purified CD8+ and CD3+ populations exhibited less MMP-9 and TIMP-1 activity. In comparison, CD56+ (NK) cells secreted barely detectable levels of proMMP-9 and TIMP-1. The secretion of proMMP-9 by PBMC and purified CD3+, CD4+, and CD8+ lymphocytes was selectively modulated by beta chemokines and proinflammatory cytokines. ProMMP-9 secretion by CD3+ and CD4+, but not by CD8+ T cells was augmented in response to TNF-alpha and IL-1, and down-regulated by IFN-gamma, while macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES (regulated upon activation and normally T cell expressed and secreted) (beta chemokines) up-regulated the secretion of proMMP-9 by all of the lymphocyte subsets tested. These results demonstrate that a number of proinflammatory cytokines and chemokines differentially regulate proMMP-9 secretion from purified CD4+ and CD8+ lymphocytes, while for purified CD3+ T cells (consisting of CD4+ and CD8+ cells in approximately a 2:1 ratio), a predominantly CD4+ lymphocyte response profile was demonstrated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036981

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Matrix metalloproteinase biology applied to vitreoretinal disorders.

Authors:  C S Sethi; T A Bailey; P J Luthert; N H Chong
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.

Authors:  Kazo Kanazawa; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 3.  The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.

Authors:  R Romero; J Espinoza; F Gotsch; J P Kusanovic; L A Friel; O Erez; S Mazaki-Tovi; N G Than; S Hassan; G Tromp
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

4.  Effects of vernal and allergic conjunctivitis on severity of keratoconus.

Authors:  Abdullah Kursat Cingu; Yasin Cinar; Fatih Mehmet Turkcu; Alparslan Sahin; Seyhmus Ari; Harun Yuksel; Muhammed Sahin; Ihsan Caca
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

5.  Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.

Authors:  Kensuke Yanashima; Panjit Chieosilapatham; Eri Yoshimoto; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

6.  Evaluation of multiple variate selection methods from a biological perspective: a nutrigenomics case study.

Authors:  Henri S Tapp; Marijana Radonjic; E Kate Kemsley; Uwe Thissen
Journal:  Genes Nutr       Date:  2012-03-02       Impact factor: 5.523

7.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 8.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

9.  Somatostatin is a specific inhibitor of SDF-1alpha-induced T cell infiltration.

Authors:  T Talme; J Ivanoff; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

10.  Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching.

Authors:  Chad Johnson; Hak-Joon Sung; Susan M Lessner; M Elizabeth Fini; Zorina S Galis
Journal:  Circ Res       Date:  2003-12-11       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.